ARTEL and IonGate Join Forces to Advance Drug Discovery Research in North America 25 June 2008 IonGate will leverage ARTEL’s expertise to increase the exposure and use of its discovery systems and assay development services in North America.
Trubion Pharmaceuticals Announces Extension of Research Period under its Wyeth Collaboration 20 June 2008 Wyeth's obligations to Trubion include collaboration research funding commitments of $3.2 million in exchange for research services through Dec. 22, 2009.
Metabolon Awarded Additional Metabolomics Patent 12 June 2008 The newly issued patent further expands the domain of previously issued patents to include multiple disease states related to nervous systems disorders.
Nuevolution Announces Drug Discovery Alliance with Lexicon Pharmaceuticals 12 June 2008 Nuevolution's Chemetics® drug discovery technology will be applied to identify small molecule lead compounds against Lexicon drug targets.
ChemDiv to Provide Schering Plough Corporation with Discovery Libraries in Multiyear Agreement 06 June 2008 Scientists of both companies will work closely to develop exclusive small molecule libraries enhancing Schering Plough's global drug discovery effort.
Acucela Doses First Subject in Phase I Trial for Age-Related Macular Degeneration 04 June 2008 Study will evaluate the safety, tolerability and pharmacokinetics of ACU-02, an orally-available small molecule for dry form of AMD.
Horizon Discovery to be a Founding-Member of Oncology Drug Discovery Consortium 29 May 2008 Horizon will be a founding member of VIMCAD, a consortium of UK Oncology research groups, funded by Cancer Research UK.
Meridian Signs Agreement in Principle to Acquire Line of Recombinant Proteins from Vybion 20 May 2008 The assets to be acquired include a portfolio of recombinant viral proteins and cardiac antigens, customer lists, supply agreements, patent and technology rights.